Surgical Considerations and Perioperative Management of Hypoparathyroidism

Dr. Ferenczi explains that American Thyroid Association statements and the surgical literature have converged on a consistent set of risk factors: total thyroidectomy, autoimmune thyroid disease, central neck dissection, substernal or retrosternal goiters, surgeon inexperience, and malabsorptive conditions. Additional independent risk factors include preoperative hypocalcemia or vitamin D deficiency, inability to visualize or preserve parathyroids intraoperatively, reoperation, large goiters, female sex, Graves disease, and Hashimoto's thyroiditis. She recommends obtaining baseline serum calcium, PTH, and 25-hydroxyvitamin D before any planned bilateral operation. Correcting vitamin D deficiency preoperatively is a modifiable risk factor that should always be addressed. If baseline calcium is already low-normal or below normal, supplementation can be started preoperatively.

She stresses the importance of distinguishing transient hypoparathyroidism—common and usually resolving within weeks to months—from permanent disease, defined as persisting beyond 12 months. Patients should be counseled candidly that permanent disease means lifelong medication and monitoring. In high-risk patients, surgeon volume matters, and parathyroid autotransplantation should be considered, as it is associated with more transient but less permanent hypoparathyroidism.

Postoperatively, early PTH measurement is the key triage tool: a PTH above 10 pg/mL at 12 to 24 hours post-thyroidectomy makes permanent hypoparathyroidism very unlikely, while a PTH below 6 pg/mL at four to six hours is a strong predictor of permanent disease. She recommends checking serum calcium within 24 hours, teaching patients to recognize symptoms of hypocalcemia—perioral and fingertip tingling, muscle cramps—before discharge, and providing explicit rescue dosing instructions. Most patients should be reassured that early hypocalcemia is often transient, and a definitive diagnosis of permanent hypoparathyroidism should not be declared until 12 months have elapsed, as late recovery can occur. For those who do progress to permanent disease, the postoperative period is the ideal time to establish the long-term monitoring relationship.

In the next episode, "Communication Strategies, Multidisciplinary Collaboration, and Future Outlook in Hypoparathyroidism," the panel discusses communication approaches for patients struggling with disease burden, the role of multidisciplinary care and patient support groups, and shares their outlook on the evolving future of hypoparathyroidism management.